Episode 4: Not a one-size-fits-all approach: Treatment and management of AL amyloidosis

While myeloma is used as a blueprint for treatment of AL amyloidosis, it does not truly reflect its complexity. Dr Anita D’Souza and Dr Kumar discuss the role of clinical trials, the use of autologous stem cell transplant, and how the nature of AL amyloidosis alters response to and side effect profiles of myeloma treatments. Dr D’Souza also offers advice on monitoring treatment response and the steps to take when response is poor.